Heart failure: the role for mineralocorticoid receptor antagonists

Heart failure: the role for mineralocorticoid receptor antagonists

Mineralocorticoid receptor antagonists (MRA’s) have been shown to be effective in patients with HFREF while their role in patients with HFPEF remains controversial. Despite a class  one indication in both the ESC and AHA/ACC heart failure guidelines in patients with HFREF MRA’s remain underused...

Full description

Bibliographic Details
Main Author: Bertram Pitt
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2014-05-01
Series:Swiss Medical Weekly
Subjects:
heart failure
mineralocorticoid receptor antagonists
Aldosterone
Online Access:https://www.smw.ch/index.php/smw/article/view/1870

Similar Items

Similar Items